Multimodal Postoperative Analgesia Following OSA Surgery
Not Applicable
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Combination Product: Nalbuphine, ketorolac, accufuser
- Registration Number
- NCT04483427
- Lead Sponsor
- Bahaa Mohammed Refaie
- Brief Summary
Assessment of the clinical efficacy and adverse effects of multimodal analgesic regimen consisting of nalbuphine combined with ketorolac using IV continuous infusion silicon device (Accufuser) for postoperative analgesia following multilevel OSA surgeries
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- physical status of American Society of Anesthesiologists (ASA) II
- age between 30 - 50 years
- OSA patients diagnosed by polysomnography and stop-bang questionnaire
- enrolled for multilevel OSA surgery
Exclusion Criteria
- history of allergy to the study drugs
- history of hepatic, cardiopulmonary or renal disease
- history of any chronic pain on medication
- history of substance abuse
- psychiatric disorder
- lack of patient cooperation.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description OSA patients after multilevel surgery Nalbuphine, ketorolac, accufuser -
- Primary Outcome Measures
Name Time Method Postoperative pain Assessment will be carried out 48 hours postoperatively Visual analog pain score
- Secondary Outcome Measures
Name Time Method Sedation level 48 hours postoperatively Ramsey Sedation Ramsey Sedation Scale
incidence of adverse effects 48 hours postoperatively hypoxia, nausea, vomiting, itching
Trial Locations
- Locations (1)
Sohag faculty of medicine
🇪🇬Sohag, Egypt